Submitted by Anonymous (not verified) on 5 May 2026 - 13:24
Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 35, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 35, Status: Authorised